ADMA Biologics, Inc.
NASDAQADMA Biologics reports Q1 results on May 8 with short sellers quietly rebuilding positions after a sharp pullback — making the earnings print a test of whether the stock's recent momentum can hold. Short interest has climbed meaningfully in recent weeks. It rose 8.3% over the past week to reach 9.4% of the free float — a notable level for a biotech of this size. The move reverses a…
Snapshot as of 22 Jun 2026
ADMA Biologics reports Q1 results on May 8 with short sellers quietly rebuilding positions after a sharp pullback — making the earnings print a test of whether the stock's recent momentum can hold. Short interest has…
ADMA Biologics reports Thursday with a familiar tension: a stock that has rallied 11.5% over the past month is now pulling back into the number, down 6% on the week to $10.25, while short interest has quietly rebuilt…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ADMA — free to start on ORTEX.
Sign up for free →Open ADMA on ORTEX